Quench For Yield:
In the diverse sector of healthcare, one has the luxury of the potential to own “risky” young stocks or mature big dividend-paying biotech/pharma plays (of course there are the providers and medical equipment and supplies too). Looking at some of the latter names one could point to PFE, which rose 1.8% this week, pays a dividend yield close to 4%. Below is the chart of another in GILD that pays a yield above 4%, and it also has an attractive chart. It trades 13% off last July highs, but above the round 70 figure could make a move toward 80 later this summer. The stock is the third largest component in the IBB, which fell “just” 1.5% this week compared to the XBI that dropped nearly 6%. Consider the IBB nows sits 8% off its most recent 52-week highs, while the XBI is 28% off its own yearly peak. The IBB was aided by MRNA’s 23% jump this week (2nd largest holding), not a typo, on its inclusion into the S&P 500. Those 2 ETFs are trading like two different animals, with the IBB very top-heavy with dividend payers.